Letter to the Editor. Stereotactic radiosurgery for cavernous malformations: does it beat the natural history?
Basel A. Taweel
Basel A. TaweelSchool of Medicine, University of Liverpool, United Kingdom Institute of Systems Molecular and Integrative Biology, University of Liverpool, United Kingdom
KaraaslanB, GülsunaB, ErolG, et al.Stereotactic radiosurgery for cerebral cavernous malformation: comparison of hemorrhage rates before and after stereotactic radiosurgery. J Neurosurg. 2022;136(3):655–661.
KaraaslanB, GülsunaB, ErolG, Stereotactic radiosurgery for cerebral cavernous malformation: comparison of hemorrhage rates before and after stereotactic radiosurgery. J Neurosurg. 2022;136(3):655–661.3445058510.3171/2021.2.JNS21138)| false
BarkerFGII, Amin-HanjaniS, ButlerWE, et al.Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery. 2001;49(1):15–25.
BarkerFGII, Amin-HanjaniS, ButlerWE, Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery. 2001;49(1):15–25.11440436)| false
SalmanR, WadeJ, HarknessK, et al.Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. National Institute for Health and Care Research. Accessed July 29, 2022. https://www.journalslibrary.nihr.ac.uk/programmes/hta/NIHR128694/#/
SalmanR, WadeJ, HarknessK, Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. National Institute for Health and Care Research. Accessed July 29, 2022. https://www.journalslibrary.nihr.ac.uk/programmes/hta/NIHR128694/#/)| false